Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

Exclusion Criteria

• •1. Patient (or their legally authorized representative) is unwilling to provide informed consent
• •2. Patient has suspected dementia of other type, e.g., Lewy body, frontotemporal disorder, vascular, etc.
• •3. Patient has documented or suspected neurological or intracranial conditions such as cerebrovascular accident, tumors, intracranial space occupying lesions, seizures or other intracranial/neurological conditions that may affect their safety in the study.
• •4. History of head and neck radiation exposure
• •5. Patient with severe kidney disease (GFR \<30 mL/min/1.73m2)
• •6. Patient with acute kidney injury
• •7. Active systemic infection under treatment with intravenous antibiotics
• •8. Patient has a modified Rankin Score (mRS) of \>4
• •9. Clinically significant cardiovascular, digestive, respiratory, endocrine, or central nervous system disorders, previous mental disorders, or other disorders that may significantly affect the data collection or the ability to comply with the protocol per the investigator's discretion
• •10. Known history of significant bleeding, coagulopathy, or Von Willebrand's disease
• •11. Patient with an active cancer diagnosis and/or currently receiving treatment for cancer or has received treatment within the past 6 months
• •12. Patient is currently receiving treatment or has been treated with anti-amyloid-beta monoclonal antibody therapy within the past 3 months
• •13. Patient has contraindication for MRI or intrathecal administration of gadobutrol
• •14. Currently enrolled in any other investigational clinical studies that the investigator believes may impact patient safety or study outcomes
• •15. Patient is ineligible to participate for other reasons in the judgment of the investigator